How big is the Asia-Pacific Blood Glucose Monitoring Market?

The Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 3.77 billion in 2024 and grow at a CAGR of 7.69% to reach USD 5.54 billion by 2029. Read More

What is the current Asia-Pacific Blood Glucose Monitoring Market size?

In 2024, the Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 3.77 billion. Read More

Who are the key players in Asia-Pacific Blood Glucose Monitoring Market?

Roche, Medtronics, Dexcom, Abbott Diabetes Care and Johnson & Johnson are the major companies operating in the Asia-Pacific Blood Glucose Monitoring Market. Read More

What years does this Asia-Pacific Blood Glucose Monitoring Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Blood Glucose Monitoring Market size was estimated at USD 3.5 billion. The report covers the Asia-Pacific Blood Glucose Monitoring Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Blood Glucose Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Blood Glucose Monitoring Market Share

Statistics for the 2023 & 2024 Asia-Pacific Blood Glucose Monitoring market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Blood Glucose Monitoring share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Asia-Pacific Blood Glucose Monitoring Industry

The Asia-Pacific Blood Glucose Monitoring Market is moderately fragmented, with few major manufacturers, including a presence in major countries of the Asia-Pacific market. In contrast, the remaining manufacturers stayed confined to the other local or region-specific markets. Mergers and acquisitions between players in the recent past helped companies strengthen their market presence.